Ad industry veteran Dave Paragamian named CEO

Health Monitor, a leading provider of integrated marketing solutions that maximize biopharmaceutical/OTC brand growth and improve health outcomes, today announced key senior-level appointments on the leadership team. Responding to years of rapid growth and signaling expectations of ongoing success, the company has appointed David Paragamian to the position of CEO. Additionally, Howard Halligan will be promoted to the position of President and Chief Operating Officer. After 16 years at the helm of Health Monitor, former CEO, Ken Freirich will be retiring.

Marketing Technology News: B2B Advertising on CTV Platforms is 2021’s Gold Rush

Mr. Paragamian brings extensive senior leadership experience to the position, including former roles as President of Razorfish Health, Group President of The ApotheCom Group, and Group President for Havas Health, as well as leadership roles in marketing and sales at Roche Diagnostics, Sanofi, Johnson & Johnson, and Procter & Gamble. He joined Health Monitor in December 2020 as President.

Mr. Paragamian noted, “I am excited to lead the next great chapter of growth at Health Monitor. We are proud of the extensive network we have built in over 200,000 physician offices and the deep content expertise of our in-house editorial and content studio. I have no doubt that our wide array of direct-to-patient marketing solutions will continue to lead the industry in quality and quantifiable impact.”

Marketing Technology News: Metis Alumni Win Honors at International Competition For Pandemic Response